A detailed history of Principal Securities, Inc. transactions in Incyte Corp stock. As of the latest transaction made, Principal Securities, Inc. holds 2,246 shares of INCY stock, worth $142,710. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,246
Previous 972 131.07%
Holding current value
$142,710
Previous $55.4 Million 145.87%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$51.18 - $63.75 $65,203 - $81,217
1,274 Added 131.07%
2,246 $136 Million
Q1 2024

May 10, 2024

BUY
$56.55 - $66.59 $46,710 - $55,003
826 Added 565.75%
972 $55.4 Million
Q4 2023

Feb 07, 2024

BUY
$52.16 - $64.19 $7,615 - $9,371
146 New
146 $9.17 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $14.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.